President Trump’s Condition: Regeneron CEO and Dr. Scott Gottlieb on POTUS Treatment

To listen to this podcast episode, click on the Play button in the bar at the bottom of the screen. To listen while browsing, click on the Expand button at the bottom right to launch the player in a new browser tab/window.

President Trump remains at Walter Reed National Military Medical Center, and treatments for his coronavirus diagnosis include an experimental antibody cocktail from Regeneron, dexamethasone, and Gilead’s remdesivir. CNBC’s Eamon Javers tracks the timeline of events since the President’s announcement, and CNBC’s Meg Tirrell explains the drugs in the President’s treatment plans. Former FDA Commissioner Dr. Scott Gottlieb deciphers the President’s likely condition from White House communications, and Regeneron CEO Dr. Leonard Schleifer discusses the status of the monoclonal antibody cocktail that was approved by the FDA for “compassionate use” in President Trump’s treatment. 

Learn more about your ad choices. Visit

Leave a Reply

Brian Kilmeade Show – 10-5-2020

Alison Arngrim – #1878-1